{"database": "lobbying", "table": "lobbying_activities", "rows": [[1662122, "feb686f2-eb89-49c8-8e86-648706e18d65", "Q1", "CAPITOL HILL STRATEGIES,  LLC", 91774, "MERCK & CO., INC", 2015, "first_quarter", "MED", "Draft 21st Century Cures legislation under consideration by the House Energy & Commerce Committee (multiple provisions including incentives for innovation to help expedite novel treatments and cures, enhancements to FDA capacity and resources, and promotion of precision therapies)", "HOUSE OF REPRESENTATIVES,SENATE", 50000, null, 0, 0, "2015-04-15T14:22:16.297000-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["1662122"], "units": {}, "query_ms": 1.942075090482831, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}